Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the efficacy and tolerability of low-dose
statin therapy vs. the association between a low-dose statin and a nutraceutical-based
protocol in high-dose statin-intolerant patients with coronary artery disease deemed to be at
high-risk.